The Organometallic Chemistry and Catalysis Group works on the synthesis of organometallic compounds with specific properties for their use in catalytic and biological applications. We develop new synthetic strategies based on catalytic methods for the functionalization of organic molecules. We are also interested in developing new metallodrugs for the treatment of human diseases, such as cancer and microbial infections.